Literature DB >> 15120278

Effects of lipid chain length on molecular interactions between paclitaxel and phospholipid within model biomembranes.

Lingyun Zhao1, Si-Shen Feng.   

Abstract

Molecular interactions between an anticancer drug, paclitaxel, and phosphatidylcholine (PC) of various chain lengths were investigated in the present work by the Langmuir film balance technique and differential scanning calorimetry (DSC). Both the lipid monolayer at the air-water interface and lipid bilayer vesicles (liposomes) were employed as model biological cell membranes. Measurement and analysis of the surface pressure versus molecular area curves of the mixed monolayers of phospholipids and paclitaxel under various molar ratio showed that phospholipids and paclitaxel formed a nonideal miscible system at the interface. Paclitaxel exerted an area-condensing effect on the lipid monolayer at small molecular surface areas and an area-expanding effect at large molecular areas, which could be explained by the intermolecular forces and geometric accommodation between the two components. Paclitaxel and phospholipids could form thermodynamically stable monolayer systems: the stability increased with the chain length in the order DMPC (C14:0)>DPPC (C16:0)>DSPC (C18:0). Investigation of paclitaxel penetration into the pure lipid monolayer showed that DMPC had a higher ability to incorporate paclitaxel and the critical surface pressure for paclitaxel penetration also increased with the chain length in the order DMPC>DPPC>DSPC. A similar trend was testified by DSC studies on vesicles of the mixed paclitaxel/phospholipids bilayer. Paclitaxel showed the greatest interaction with DMPC while little interaction could be measured in the paclitaxel/DSPC liposomes. Paclitaxel caused broadening of the main phase transition without significant change at the peak melting temperature of the phospholipid bilayers, which demonstrated that paclitaxel was localized in the outer hydrophobic cooperative zone of the bilayer. The interaction between paclitaxel and phospholipid was nonspecific and the dominant factor in this interaction was the van der Waals force or hydrophobic force. As the result of the lower net van der Waals interaction between hydrocarbon chains for the shorter acyl chains, paclitaxel interacted more readily with phospholipids of shorter chain length, which also increased the bilayer intermolecular spacing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15120278     DOI: 10.1016/j.jcis.2003.12.009

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  13 in total

1.  Predicting the solubility of the anti-cancer agent docetaxel in small molecule excipients using computational methods.

Authors:  Loan Huynh; Justin Grant; Jean-Christophe Leroux; Pascal Delmas; Christine Allen
Journal:  Pharm Res       Date:  2007-08-18       Impact factor: 4.200

2.  Investigation of the adsorption of PEG1500-12-acyloxystearate surfactants onto phospholipid bilayers: an ellipsometry and cryo-TEM study.

Authors:  Mauro Vaccaro; Christian von Corswant; Olle Söderman
Journal:  Biophys J       Date:  2007-08-31       Impact factor: 4.033

3.  Rational Design of Cholesterol Derivative for Improved Stability of Paclitaxel Cationic Liposomes.

Authors:  Jasmin Monpara; Chryso Kanthou; Gillian M Tozer; Pradeep R Vavia
Journal:  Pharm Res       Date:  2018-03-08       Impact factor: 4.200

4.  Mechanisms of drug sensitization to TRA-8, an agonistic death receptor 5 antibody, involve modulation of the intrinsic apoptotic pathway in human breast cancer cells.

Authors:  Hope M Amm; Tong Zhou; Adam D Steg; Huichien Kuo; Yufeng Li; Donald J Buchsbaum
Journal:  Mol Cancer Res       Date:  2011-02-25       Impact factor: 5.852

5.  Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer.

Authors:  Ketan Patel; Ravi Doddapaneni; Nusrat Chowdhury; Cedar Ha Boakye; Gautam Behl; Mandip Singh
Journal:  Nanomedicine (Lond)       Date:  2016-05-12       Impact factor: 5.307

6.  Effect of anti-DR5 and chemotherapy on basal-like breast cancer.

Authors:  Patsy G Oliver; Albert F LoBuglio; Tong Zhou; Andres Forero; Hyunki Kim; Kurt R Zinn; Guihua Zhai; Yufeng Li; Choo H Lee; Donald J Buchsbaum
Journal:  Breast Cancer Res Treat       Date:  2011-09-07       Impact factor: 4.872

7.  Role of cholesterol, DOTAP, and DPPC in prostasome/spermatozoa interaction and fusion.

Authors:  Carlo A Palmerini; Cesare Cametti; Simona Sennato; Diego Gaudino; Enrico Carlini; Federico Bordi; Giuseppe Arienti
Journal:  J Membr Biol       Date:  2006-11-07       Impact factor: 1.843

8.  Effect of fluidizing agents on paclitaxel penetration in cervical cancerous monolayer membranes.

Authors:  A Preetha; N Huilgol; R Banerjee
Journal:  J Membr Biol       Date:  2007-08-22       Impact factor: 1.843

9.  Fluorescence anisotropy, FT-IR spectroscopy and 31-P NMR studies on the interaction of paclitaxel with lipid bilayers.

Authors:  Anand Babu Dhanikula; Ramesh Panchagnula
Journal:  Lipids       Date:  2008-05-06       Impact factor: 1.880

10.  Phospholipid metabolism in an industry microalga Chlorella sorokiniana: the impact of inoculum sizes.

Authors:  Shuhuan Lu; Jiangxin Wang; Qian Ma; Jie Yang; Xia Li; Ying-Jin Yuan
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.